Expiratory muscle strength training for airway protective dysfunction in Parkinson’s Disease presented by Dr. Michelle Troche
Aspire Respiratory Products is pleased to host another great presentation in a series of free speaker events offered to health-focused professionals in 2021. The series brings experts together to share and discuss important health and physical wellbeing topics. This next event, expiratory muscle strength training for airway protective dysfunction in Parkinson’s Disease is being presented by the highly respected Dr. Michelle Troche.
Event Overview: This presentation will discuss the evidence to support the use of expiratory muscle strength training in patients with Parkinson’s Disease. The presentation will focus on the findings of two large clinical trials and a telehealth feasibility study testing EMST in PD for airway protective outcomes, for which the presenter served as first-author and/or PI. The presentation will emphasize the clinically translatable findings primarily targeting swallowing, reflex cough, and voluntary cough outcomes Attendees will hear the perspective of a respiratory therapist on intrinsic factors that can affect the outcome of respiratory muscle strength training outcomes elevating the knowledge and skills of clinicians working with respiratory muscle strength training protocols in patient care.
About Dr. Troche: Dr. Michelle S. Troche is currently an Associate Professor and Program Director in the Communication Sciences and Disorders Program, Department of Biobehavioral Sciences at Teachers College, Columbia University. She holds adjunct positions in the Departments of Neurology and Otolaryngology. She directs the Laboratory for the Study of Upper Airway Dysfunction. Her research is aimed at developing robust evaluation and treatment techniques for dystussia and dysphagia. Her research has been funded by the National Institutes of Health, Michael J Fox Foundation, CurePSP Foundation, and National Ataxia Foundation. Dr. Troche’s work is of significant impact given that aspiration pneumonia secondary to swallowing and cough disorders is a leading cause of death in most neurogenic populations.
- The 45-minute event will include a 30-minute presentation by Dr. Troche and a 15 minute Q & A session
- Dr. Sapienza will discuss with Dr. Troche her opinions of expiratory muscle strength training as a restorative treatment option relative to other known evidence-based exercise-based treatments for those with Parkinson’s disease.
- Moderator will guide discussion from attendees that will desire to further discuss the Class 1 evidence shown during the presentation.